# Sample Pharmaceutical Analytical Method Validation Protocols

## 1. Amoxicillin Tablets 500mg - HPLC Assay Method Validation Protocol

### Product Information
- **Product Name**: Amoxicillin Tablets
- **Strength**: 500 mg
- **Reference Standards**: USP, European Pharmacopoeia (EP)
- **Method Type**: HPLC-UV for Assay and Related Substances

### Test Method

#### HPLC Conditions
- **Column**: Phenomenex Luna C18 (4.6 × 250 mm, 5 μm)
- **Mobile Phase**: Acetonitrile : 0.01M Phosphate Buffer pH 5.0 (15:85 v/v)
- **Flow Rate**: 1.0 mL/min
- **Detection**: UV at 254 nm
- **Injection Volume**: 20 μL
- **Column Temperature**: 25°C
- **Run Time**: 10 minutes

#### Sample Preparation
1. Weigh and finely powder not fewer than 20 tablets
2. Transfer accurately weighed portion of powder equivalent to 100 mg amoxicillin to 100 mL volumetric flask
3. Add 70 mL of mobile phase and sonicate for 15 minutes
4. Dilute to volume with mobile phase and mix
5. Filter through 0.45 μm membrane filter
6. Further dilute 5 mL to 50 mL with mobile phase

### Validation Parameters and Acceptance Criteria

#### 1. System Suitability
- **Tailing Factor**: NMT 2.0
- **Theoretical Plates**: NLT 2000
- **%RSD of Peak Area** (6 injections): NMT 2.0%
- **Resolution**: NLT 2.0 between amoxicillin and any impurity peak

#### 2. Specificity
- **Acceptance Criteria**: No interference from placebo, diluent, or degradation products
- **Forced Degradation Conditions**:
  - Acid: 0.1N HCl at 60°C for 30 minutes
  - Base: 0.1N NaOH at 60°C for 30 minutes  
  - Oxidation: 3% H2O2 at room temperature for 30 minutes
  - Thermal: 105°C for 24 hours
  - Photolytic: UV light (254 nm) for 24 hours

#### 3. Linearity
- **Range**: 50% to 150% of working concentration (0.05-0.15 mg/mL)
- **Levels**: 5 (50%, 75%, 100%, 125%, 150%)
- **Acceptance Criteria**: 
  - Correlation coefficient (r²) ≥ 0.999
  - Y-intercept: NMT ±2.0% of 100% response

#### 4. Accuracy (Recovery)
- **Levels**: 50%, 100%, 150% (3 preparations each)
- **Acceptance Criteria**: 
  - Individual recovery: 98.0% - 102.0%
  - Mean recovery: 98.0% - 102.0%
  - %RSD: NMT 2.0%

#### 5. Precision
- **Repeatability**: 6 determinations at 100% level
  - Acceptance: %RSD NMT 2.0%
- **Intermediate Precision**: Different day, analyst, equipment
  - Acceptance: %RSD NMT 3.0%

#### 6. Range
- **Assay Range**: 80% - 120% of label claim
- **Acceptance**: Method meets accuracy, linearity, and precision within this range

#### 7. Robustness
- **Parameters to Evaluate**:
  - Mobile phase pH: ±0.2 units
  - Flow rate: ±0.1 mL/min
  - Column temperature: ±5°C
  - Mobile phase composition: ±2%
- **Acceptance**: System suitability criteria met, assay within 98.0-102.0%

#### 8. Solution Stability
- **Standard Solution**: Stable for 48 hours at room temperature
- **Sample Solution**: Stable for 24 hours at room temperature
- **Acceptance**: Change in assay value NMT 2.0%

### Related Substances Test

#### Acceptance Criteria
- **Amoxicillin Penicilloic Acid**: NMT 1.0%
- **Amoxicillin Penilloic Acid**: NMT 1.0%
- **Any Unspecified Impurity**: NMT 0.5%
- **Total Impurities**: NMT 3.0%

#### Limit of Detection/Quantitation
- **LOD**: 0.05% (S/N ratio ≥ 3)
- **LOQ**: 0.15% (S/N ratio ≥ 10, %RSD NMT 10%)

## 2. Metformin HCl Tablets 500mg - Assay and Related Substances

### Product Information
- **Product Name**: Metformin Hydrochloride Tablets
- **Strength**: 500 mg
- **Reference**: USP Monograph, EP Monograph
- **Method**: HPLC with UV Detection

### HPLC Method Parameters

#### Chromatographic Conditions
- **Column**: Waters Symmetry C18 (4.6 × 150 mm, 3.5 μm)
- **Mobile Phase A**: 10 mM Sodium dihydrogen phosphate buffer pH 3.0
- **Mobile Phase B**: Acetonitrile
- **Gradient Program**:
  - 0-5 min: 95% A, 5% B
  - 5-15 min: 95% A → 50% A
  - 15-20 min: 50% A
  - 20-21 min: 50% A → 95% A
  - 21-30 min: 95% A (re-equilibration)
- **Flow Rate**: 1.2 mL/min
- **Detection**: UV at 218 nm
- **Column Temperature**: 30°C
- **Injection Volume**: 10 μL

#### Sample Preparation for Assay
1. Weigh and powder not less than 20 tablets
2. Transfer powder equivalent to 100 mg metformin HCl to 200 mL flask
3. Add 150 mL of water, sonicate for 20 minutes
4. Dilute to volume with water and filter
5. Dilute 5 mL to 100 mL with mobile phase A

### Validation Requirements

#### System Suitability (Assay)
- **Retention Time**: Metformin peak at approximately 3.5 minutes
- **Tailing Factor**: NMT 1.5
- **Theoretical Plates**: NLT 5000
- **%RSD** (5 replicate injections): NMT 1.0%

#### Specificity
- **Peak Purity**: Purity angle less than purity threshold
- **Placebo Interference**: No peaks at retention time of metformin
- **Known Impurities Resolution**: 
  - Metformin impurity A (Cyanoguanidine): Resolution NLT 2.0
  - Metformin impurity B (1-Methylbiguanide): Resolution NLT 2.0

#### Linearity and Range
- **Assay**: 80-120% (400-600 μg/mL)
- **Related Substances**: LOQ to 200% of specification limit
- **Correlation Coefficient**: NLT 0.999
- **Residuals**: Randomly distributed

#### Accuracy
- **Levels**: 80%, 100%, 120% (triplicate at each level)
- **Recovery Limits**: 98.5% - 101.5%
- **Overall %RSD**: NMT 1.5%

#### Precision
- **Repeatability** (n=6): %RSD NMT 1.0%
- **Intermediate Precision**: %RSD NMT 2.0%
- **Reproducibility**: To be established during method transfer

#### Related Substances Limits
- **Cyanoguanidine**: NMT 0.02%
- **1-Methylbiguanide**: NMT 0.05%
- **Any Unspecified Impurity**: NMT 0.10%
- **Total Impurities**: NMT 0.25%

#### Detection and Quantitation Limits
- **LOD**: 0.01% (based on S/N = 3)
- **LOQ**: 0.03% (based on S/N = 10)
- **LOQ Precision**: %RSD NMT 5.0%

## 3. Atorvastatin Calcium Tablets 20mg - Comprehensive Validation Protocol

### Product Details
- **Drug Product**: Atorvastatin Calcium Tablets
- **Label Claim**: 20 mg (equivalent to atorvastatin)
- **Pharmacopeial Reference**: USP, Ph. Eur.
- **Analytical Technique**: RP-HPLC with PDA Detection

### Analytical Method

#### Chromatographic Parameters
- **Column**: Agilent Zorbax SB-C18 (4.6 × 150 mm, 3.5 μm)
- **Mobile Phase**: 
  - Buffer: 0.1% Phosphoric acid in water
  - Organic: Acetonitrile
  - Ratio: 45:55 (v/v)
- **Flow Rate**: 1.5 mL/min
- **Detection**: 244 nm (PDA detector)
- **Column Temperature**: 35°C
- **Autosampler Temperature**: 5°C
- **Run Time**: 12 minutes

#### Standard Preparation
1. Accurately weigh 22 mg of atorvastatin calcium RS
2. Transfer to 100 mL volumetric flask
3. Dissolve in 70 mL of methanol:water (80:20)
4. Sonicate for 10 minutes and dilute to volume
5. Further dilute 5 mL to 25 mL with mobile phase

### Validation Protocol

#### 1. System Suitability Requirements
- **Retention Time**: 6.5 ± 0.5 minutes
- **USP Tailing**: NMT 1.5
- **USP Plate Count**: NLT 8000
- **%RSD** (6 injections): NMT 1.0%
- **Resolution** (critical pair): NLT 2.0

#### 2. Forced Degradation Study

| Stress Condition | Parameters | Degradation Target |
|-----------------|------------|-------------------|
| Acid Hydrolysis | 1N HCl, 80°C, 2 hours | 10-20% |
| Base Hydrolysis | 1N NaOH, 80°C, 30 min | 10-20% |
| Oxidation | 10% H2O2, RT, 24 hours | 5-15% |
| Thermal | 105°C, 48 hours | 5-10% |
| Photolytic | ICH conditions | 5-10% |

#### 3. Method Validation Parameters

##### Specificity/Selectivity
- No interference from excipients
- Peak purity index > 0.9999
- Baseline resolution from all degradants

##### Linearity
- **Range**: 25% to 200% of nominal (5-40 μg/mL)
- **Data Points**: 7 levels, duplicate injections
- **Acceptance**: 
  - r² ≥ 0.9995
  - Y-intercept: ±2.0% of 100% response
  - Residual plot: Random distribution

##### Accuracy
- **Spike Levels**: 50%, 75%, 100%, 125%, 150%
- **Replicates**: n=3 at each level
- **Recovery**: 99.0% - 101.0%
- **Overall RSD**: ≤ 1.5%

##### Precision

| Type | Acceptance Criteria |
|------|--------------------|
| Repeatability (n=6) | %RSD ≤ 1.0% |
| Intermediate (2 days, 2 analysts) | %RSD ≤ 2.0% |
| Reproducibility | %RSD ≤ 3.0% |

##### Robustness Testing Matrix

| Parameter | Variation | Acceptance |
|-----------|-----------|------------|
| pH of buffer | ±0.1 units | Assay: 99-101% |
| Organic phase | ±2% | Rs ≥ 2.0 |
| Flow rate | ±0.2 mL/min | USP tailing ≤ 1.5 |
| Column temp | ±5°C | %RSD ≤ 2.0% |
| Wavelength | ±2 nm | Assay: 99-101% |

#### 4. Related Substances/Impurities

##### Specified Impurities
- **Atorvastatin Impurity A**: NMT 0.2%
- **Atorvastatin Impurity B**: NMT 0.2%
- **Atorvastatin Impurity C**: NMT 0.15%
- **Atorvastatin Impurity D**: NMT 0.15%
- **Atorvastatin Lactone**: NMT 0.3%

##### Unspecified Impurities
- **Individual**: NMT 0.10%
- **Total**: NMT 1.0%

##### Sensitivity
- **LOD**: 0.03% (S/N ≥ 3:1)
- **LOQ**: 0.10% (S/N ≥ 10:1, RSD ≤ 5%)

#### 5. Solution Stability Protocol

| Solution Type | Storage Condition | Time Points | Acceptance |
|--------------|-------------------|-------------|------------|
| Standard | 2-8°C | 0, 24, 48, 72 h | 98.0-102.0% |
| Sample | 2-8°C | 0, 12, 24, 48 h | 98.0-102.0% |
| Standard | 25°C | 0, 8, 16, 24 h | 98.0-102.0% |
| Sample | 25°C | 0, 8, 16, 24 h | 98.0-102.0% |

### Compliance Requirements

#### ICH Q2(R1) Guidelines
- All validation parameters as per ICH Q2(R1)
- Statistical evaluation of linearity
- Intermediate precision across different conditions

#### USP <1225> Requirements
- Compendial method verification
- System suitability before each analysis
- Ongoing method performance monitoring

#### European Pharmacopoeia
- Compliance with general chapter 2.2.46
- Peak identification by relative retention
- Impurity reporting above identification threshold

## 4. Ibuprofen Tablets 400mg - Dissolution Test Validation

### Product Information
- **Product**: Ibuprofen Tablets
- **Strength**: 400 mg
- **Test**: Dissolution (USP Apparatus 2)
- **Detection**: UV Spectrophotometry

### Dissolution Parameters
- **Apparatus**: USP Type 2 (Paddle)
- **Speed**: 50 rpm
- **Medium**: Phosphate Buffer pH 7.2
- **Volume**: 900 mL
- **Temperature**: 37.0 ± 0.5°C
- **Sampling Times**: 5, 10, 15, 20, 30, 45 minutes
- **Detection**: UV at 221 nm

### Validation Requirements

#### Specificity
- No interference from excipients at 221 nm
- Placebo shows no significant absorbance

#### Linearity
- **Range**: 10% to 130% of label claim (44.4 - 577.8 μg/mL)
- **Correlation Coefficient**: r² ≥ 0.999

#### Accuracy
- **Levels**: 10%, 50%, 100%, 130%
- **Recovery**: 98.0% - 102.0%
- **RSD**: ≤ 2.0%

#### Precision
- **Repeatability**: 6 tablets, RSD ≤ 5.0%
- **Intermediate**: Different days/analysts, RSD ≤ 7.0%

#### Solution Stability
- Samples stable for 24 hours at room temperature
- Standard stable for 48 hours at room temperature

#### Acceptance Criteria
- **Q = 80% in 30 minutes**
- Not less than 80% (Q) of labeled amount dissolves in 30 minutes

## Regulatory Compliance Summary

All methods comply with:
1. **ICH Q2(R1)**: Validation of Analytical Procedures
2. **USP <1225>**: Validation of Compendial Methods
3. **USP <1226>**: Verification of Compendial Methods
4. **EP 2.2.46**: Chromatographic Separation Techniques
5. **FDA Guidance**: Analytical Procedures and Methods Validation for Drugs and Biologics

### Documentation Requirements
1. Approved validation protocol before execution
2. Detailed experimental records with raw data
3. Summary report with statistical analysis
4. Method validation certificate
5. Change control for any modifications
6. Annual method review and trending